Petco Health and Wellness... (WOOF)
NASDAQ: WOOF
· Real-Time Price · USD
3.63
-0.02 (-0.55%)
At close: May 22, 2025, 11:27 AM
Petco Health and Wellness Revenue Breakdown
Period Ending | Feb 3, 2024 | Jan 28, 2023 | Jan 29, 2022 |
---|---|---|---|
Consumables Revenue | 3.06B | 2.86B | 2.53B |
Consumables Revenue Growth | +7.14% | +12.86% | n/a |
Services And Other Revenue | 981.57M | 805.45M | 670.29M |
Services And Other Revenue Growth | +21.87% | +20.16% | n/a |
Supplies And Companion Animals Revenue | 2.21B | 2.37B | 2.6B |
Supplies And Companion Animals Revenue Growth | -6.79% | -8.92% | n/a |
Operating Expense Breakdown
Period Ending | Feb 1, 2025 | Nov 2, 2024 | Aug 3, 2024 | May 4, 2024 | Feb 3, 2024 | Oct 28, 2023 | Jul 29, 2023 | Apr 29, 2023 | Jan 28, 2023 | Oct 29, 2022 | Jul 30, 2022 | Apr 30, 2022 | Jan 29, 2022 | Oct 30, 2021 | Jul 31, 2021 | May 1, 2021 | Jan 30, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Nov 2, 2019 | Aug 3, 2019 | May 3, 2019 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 571.87M | 571.78M | 578.26M | 595.44M | 606.18M | 559.61M | 568.97M | 576.87M | 549.72M | 549.62M | 544.47M | 557.74M | 552.6M | 532.76M | 525.94M | 549.24M | 502.29M | 495.4M | 464.71M | 449.92M | 437.56M | 448.2M | 445.08M | 445.08M | 59.78M | 58.4M | 57.06M | 49.34M | 48.19M | 50.13M | 50.25M | 44.86M | 44.48M | 44.4M |
Selling, General, and Administrative Revenue Growth | +0.02% | -1.12% | -2.89% | -1.77% | +8.32% | -1.64% | -1.37% | +4.94% | +0.02% | +0.95% | -2.38% | +0.93% | +3.72% | +1.30% | -4.24% | +9.35% | +1.39% | +6.61% | +3.29% | +2.82% | -2.37% | +0.70% | 0.00% | +644.57% | +2.35% | +2.34% | +15.65% | +2.39% | -3.87% | -0.25% | +12.02% | +0.84% | +0.20% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |